StockWatch
·
Medicinal Chemicals & Botanical Products
Quarterly ResultJun 9, 2026, 06:07 AM

AIBOTICS Q1 Net Loss $(418K); Going Concern Doubt Raised

AI Summary

AIBOTICS, INC. reported a net loss of $(418,105) for Q1 2026, an improvement from $(591,397) in Q1 2025, despite generating no revenue. The company faces substantial doubt about its ability to continue as a going concern due to minimal revenues, negative operating cash flows, and a working capital deficit of $4.72 million. Cash increased to $288,858, partly due to $69,176 in financing activities, including a Regulation A equity issuance and conversion of accrued interest into common stock.

Key Highlights

  • Reported a net loss of $(418,105) for Q1 2026, compared to $(591,397) in Q1 2025.
  • Generated no revenue in Q1 2026, down from $2,183 in Q1 2025.
  • Had a working capital deficit of $(4,720,284) as of March 31, 2026.
  • Cash balance increased to $288,858 as of March 31, 2026, from $255,940 at December 31, 2025.
  • Total liabilities increased to $5,051,334 as of March 31, 2026, from $4,834,905 at December 31, 2025.
  • Issued 25,572,128 common shares for approximately $76.7 thousand in a Regulation A equity issuance.
  • Issued 26,900,000 common shares to convert $21.5 thousand of accrued interest.
  • Management noted substantial doubt about the company's ability to continue as a going concern.